The page lists 224 projects related to the topic "alzheimer".
| # | |||
|---|---|---|---|
| 1 | REPROWORM | Safeguarding Cell Identities: Mechanisms Counteracting Cell Fate Reprogramming | 2015 |
| 2 | aLzINK | Alzheimer's disease and Zinc: the missing link ? | 2015 |
| 3 | NDI | Nano-diamond tracers for MRI molecular imaging | 2014 |
| 4 | BAS-SBBT | Bacterial Amyloid Secretion: Structural Biology and Biotechnology. | 2015 |
| 5 | CAREMiBRAIN | A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline | 2014 |
| 6 | THALAMODEL | Multimodal, high-resolution modeling of the thalamus for neuroimaging studies: application to dyslexia | 2015 |
| 7 | NIBSAD | Electrophysiological markers of cognitive processes and neuroplasticity in healthy ageing and Alzheimer`s disease | 2015 |
| 8 | MoTOR | Analysis of the “moonlighting” proteins in the mTOR-signalling pathway | 2016 |
| 9 | CHELALZ | Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies | 2016 |
| 10 | iRhom2 in AD | iRhom2 in neuroinflammation and pathogenesis of Alzheimer’s Disease | 2015 |
| 11 | NeuroRhomboid | Discovering the signalling pathways and physiology of active rhomboid proteases in the brain | 2015 |
| 12 | nAChR PAM-to-gate | Gating mechanism and pharmacological modulation of nicotinic acetylcholine receptors | 2015 |
| 13 | SorCSbalance | Role of the sorting receptor SorCS1 in controlling excitation/inhibition balance in neural circuits. | 2015 |
| 14 | CONTESSA | COuNt data TimE SerieS Analysis: significance tests and sequencing data application | 2015 |
| 15 | GWAFH | Emulsar: give the world appetite for health. | 2015 |
| 16 | Dementia | DNA rEpair impaired Mice with accElerated Neurodegeneration as Tool to Improve Alzheimer therapeutics | 2015 |
| 17 | MEMEMTUM | Neurological evaluation with simple tools to track evolution and perform early detection of neurodegenerative issues | 2015 |
| 18 | OPTIMALZ | Optical imaging of ocular pathology in Alzheimer’s disease | 2015 |
| 19 | E-SPACE | European Standardised Process Approach to Cognitive Evaluation in older people | 2016 |
| 20 | ADiRaS | Alzheimer’s Disease Diagnosis by Spectroscopy. Accurate and Non-Invasive Medical Device for the Diagnosis of Early Stage Alzheimer's Disease. | 2015 |
| 21 | BeadDiagnosis | Prognosis and Diagnosis of Protein Misfolding Diseases by Seeded Aggregation in Microspheres | 2015 |
| 22 | ADDIA | Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease | 2015 |
| 23 | CaSR Biomedicine | Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases | 2016 |
| 24 | UPR NEURO | The Unfolded Protein Response in Neurodegeneration | 2015 |
| 25 | TASPPI | Targeted small-molecule Stabilisation of Protein-Protein Interactions | 2016 |
| 26 | BtRAIN | Brain barriers training | 2015 |
| 27 | SyDAD | Synaptic Dysfunction in Alzheimer Disease | 2015 |
| 28 | Oligomers | Characterising protein oligomers and their role in neurodegenerative disease in humans | 2015 |
| 29 | JPsustaiND | Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases | 2015 |
| 30 | VESCEL | Vascular Engineering on chip using differentiated Stem Cells | 2015 |
| 31 | PRION2020 | Function and malfunction of the prion protein | 2015 |
| 32 | microCrysFact | Microfluidic Crystal Factories (μ-CrysFact): a breakthrough approach for crystal engineering | 2016 |
| 33 | MemoMCI | Targeting reconsolidation to strengthen memories in individuals with Mild Cognitive Impairment | 2016 |
| 34 | EuroPOND | Data-driven models for Progression Of Neurological Disease | 2016 |
| 35 | CoSTREAM | Common mechanisms and pathways in Stroke and Alzheimer's disease. | 2015 |
| 36 | MEDIT-AGEING | Investigating the impact of meditation training on mental health and wellbeing in the ageing population | 2016 |
| 37 | ADOPT BBMRI-ERIC | implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC | 2015 |
| 38 | ICT4Life | ICT services for Life Improvement For the Elderly | 2016 |
| 39 | MinD | Designing for People with Dementia: designing for mindful self-empowerment and social engagement | 2016 |
| 40 | IMPEDE | Immunomodulatory effects of sustained pantethine release in inflammatory diseases | 2016 |
| 41 | REFLEX | Studying the role of the retrosplenial cortex in flexible learning | 2016 |
| 42 | ARCA | Analysis and Representation of Complex Activities in Videos | 2016 |
| 43 | DIALOY | Mosaic loss of chromosome Y (LOY) in blood cells - a new biomarker for risk of cancer and Alzheimer’s disease in men | 2016 |
| 44 | PANA | PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES. | 2016 |
| 45 | MPA-ND | Membrane protein aggregation and its links with neurodegenerative diseases | 2016 |
| 46 | NEUROTUNN | Mechanisms of α-synuclein spreading, implications for synucleinopathies | 2016 |
| 47 | CONNECT | Connecting neuronal network activity with regional specificity for Alzheimer pathology: a multi-modal neuroimaging approach | 2018 |
| 48 | ElectroMAD | The Fast Periodic Visual Stimulation: a sensitive and objective approach to identify early cognitive markers of AD | 2016 |
| 49 | VIBRANT-BIO | High-throughput vibrational fingerprinting by nanoplasmonics for disease biology | 2017 |
| 50 | NPAD | Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease | 2016 |
| 51 | AD-gut | Alzheimer Disease - gut connection | 2016 |
| 52 | ORACLE | Origins of Alzheimer's disease across the life-course | 2016 |
| 53 | Neurotoxic | An Ultra-sensitive Assay to Measure Oligomer Induced Toxicity in Human Cerebrospinal Fluid | 2016 |
| 54 | LIQUIDMASS | High throughput mass spectrometry of single proteins in liquid environment | 2016 |
| 55 | IMMUNOALZHEIMER | The role of immune cells in Alzheimer's disease | 2016 |
| 56 | CAREMIBRAIN | A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline | 2016 |
| 57 | AD-VIP | Alzheimer’s disease and AAV9: Use of a virus-based delivery system for vectored immunoprophylaxis in dementia. | 2016 |
| 58 | LYSOSOMICS | Functional Genomics of the Lysosome | 2016 |
| 59 | BEND | Bendable Bioplatform for Electrically stimulated Neuronal Differentiation | 2016 |
| 60 | BBDiag | Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease | 2017 |
| 61 | SYNDEGEN | Synaptic dysfunction in Neurodegenerative Diseases | 2017 |
| 62 | DEMO | Dementia modelling | 2016 |
| 63 | REMIX | Regulation of mitochondrial expression | 2016 |
| 64 | CholAminCo | Synergy and antagonism of cholinergic and dopaminergic systems in associative learning | 2017 |
| 65 | MADIA | Magnetic DIagnostic Assay for neurodegenerative diseases | 2017 |
| 66 | ALZSYN | Imaging synaptic contributors to dementia | 2016 |
| 67 | PATHAD | Pathways to Alzheimer's disease | 2016 |
| 68 | T2DM and AD | Study of the interaction between metabolic stress and a specific genetic background on the contribution of sporadic Alzheimer's Disease | 2017 |
| 69 | AlzDiabetes | Insulin resistance and Tauopathy : Insights from Drosophila models and human brain samples | 2016 |
| 70 | URBACH-ALZ | Hyper-emotionality after neurodegenerative loss of inhibition of the amygdala | 2017 |
| 71 | NOC | Nerve-on-Chips | 2016 |
| 72 | ArrestAD | 3-O-sulfated heparan sulfate translocation in altered membrane biology: A new strategy for early population screening and halting Alzheimer’s neurodegeneration | 2017 |
| 73 | NEW-AGE | A next-generation platform for catalysing pre-clinical development of drugs against Alzheimer’s and other degenerative diseases of old-age | 2017 |
| 74 | NeuronAgeScreen | A Drug Discovery and Target Identification Screening Platform for Age-Associated Neurodegenerative Disorders | 2017 |
| 75 | eWAD | Unbalanced Wnt signalling in AD: a DNA methylation effect | 2017 |
| 76 | MacroStability | Stability and dynamics at different spatial scales: From physiology to Alzheimer's degeneration | 2017 |
| 77 | CoALIVE | Coenzyme A – Launch of In Vivo Experiments | 2017 |
| 78 | ZINCLAPS | Light-addressable potentiometric sensors (LAPS) for zinc imaging with high spatiotemporal resolution for elucidating the role of zinc in age related macular degeneration. | 2017 |
| 79 | meltRBP | Tracking interactions between RNA and RNA-binding proteins by thermal profiling of the proteome | 2017 |
| 80 | REVERSING TAUOPATHY | Identifying and deciphering the mechanism of the cellular machinery responsible for disaggregation of intracellular prion-like Tau aggregates | 2017 |
| 81 | MINERVA | MIcrobiota-Gut-BraiN EngineeRed platform to eVAluate intestinal microflora impact on brain functionality | 2017 |
| 82 | FreezeAlz | Theoretical prediction of spectral biomarkers for Alzheimer's disease enabled by highly efficient and adaptable mutli-level response methods | 2017 |
| 83 | NanoALS | Nanoparticle-based immunization, a novel therapeutic strategy for amyotrophic lateral sclerosis | 2018 |
| 84 | PCAGED-KI | Photocaged Kinase Inhibitors as Molecular Tools for Investigating Neurodegenerative Diseases | 2017 |
| 85 | umCryofix | A microfluidic cryofixation method for time-resolved correlative microscopy | 2017 |
| 86 | PRISM | Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 | 2016 |
| 87 | AMYPAD | Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 | 2016 |
| 88 | PHAGO | Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 | 2016 |
| 89 | NeuroTRACK | Tracking and predicting neurodegeneration spreading across the brain connectome | 2017 |
| 90 | INFLAMM-ALZ | The Role of Neuroinflammation in Alzheimer’s Disease | 2017 |
| 91 | funcSOFI-PD | Quantitative super-resolution optical fluctuation and phase microscopy for structural and functional imaging of Parkinson's disease | 2017 |
| 92 | BioALFA | The effect of pro-aging and pro-youthful blood factors in normal ageing and Alzheimer’s disease: a multimodal approach | 2018 |
| 93 | Tau Seeding | Identification and validation of human proteins that control tau seeding in cell-based and in vivo models | 2017 |
| 94 | MITOQUAD | Unveiling the mitochondrial role of DNA2, a human helicase-nuclease causing mtDNA deletion associated syndrome. | 2018 |
| 95 | MEMENTO | MEMory processing in the human ENTOrhinal cortex | 2017 |
| 96 | IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 | 2017 |
| 97 | FASTER | Faster magic-angle spinning leads to a resolution revolution in biological solid-state NMR | 2017 |
| 98 | CORFEDITING | Gene Editing as Therapeutic Strategy for C9ORF72 Linked ALS/FTD | 2017 |
| 99 | BETACONTROL | Control of amyloid formation via beta-hairpin molecular recognition features | 2017 |
| 100 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
| 101 | ImmuneCheckpointsAD | Immune checkpoint blockade for fighting Alzheimer’s disease | 2017 |
| 102 | PRIMATE-TE-IMPACT | Mapping the retrotransposon-mediated layer of neuronal gene regulation in the human genome | 2017 |
| 103 | ULTIMATE | The best online drug discovery platform, Building the Ultimate chemical database for drug discovery | 2017 |
| 104 | BrainDrain | Translational implications of the discovery of brain-draining lymphatics | 2017 |
| 105 | TAPAS | Training Network on Automatic Processing of PAthological Speech | 2017 |
| 106 | BrainEnergy | Control of cerebral blood flow by capillary pericytes in health and disease | 2017 |
| 107 | EQIPD | European Quality In Preclinical Data | 2017 |
| 108 | Dam2Age | DNA Damage and Repair and its Impact on Healthy Ageing | 2017 |
| 109 | M-GATE | Memory research: Ground-breaking, Applied, and Technological Exchanges | 2017 |
| 110 | LIFEGATE | Holographic super-resolution micro-endoscopy for in-vivo applications | 2017 |
| 111 | SUGARCODING | The neuroenergetics of memory consolidation – hybrid PET/MR imaging of the default mode network | 2018 |
| 112 | UPRECON | Ultrafast photonics for the detection and recognition of toxic spine-structures of amyloid aggregates linked to neurodegenerative disease | 2018 |
| 113 | INNOPREFAT | Natural Food formulation for the prevention and treatment the Obesity and Metabolic Syndrome obtained with herbal extracts | 2017 |
| 114 | NeuroPsyCAD | Artificial Intelligence for early and accurate neuropsychiatric diagnosis | 2017 |
| 115 | BTech | Novel human neurodegenerative disease specific 3D cell-models with applications in drug development and toxicity testing | 2018 |
| 116 | GOKNOT | Modelling the formation of a gordian knot in Human Ubiquitin Hydrolase | 2018 |
| 117 | CC-LEGO | CC-LEGO: robust protein blocks to build cages and layers | 2018 |
| 118 | IPACBIS | Identifying preclinical Alzheimer´s disease in the community using a panel of biomarkers among individuals with Subjective Memory Complaints | 2018 |
| 119 | BOLD-NMR | Biomolecular structures elucidated by cOLD magic angle spinning NMR with dynamic nuclear polarization | 2018 |
| 120 | NanoMop | Smart Cholesterol-Mopping Polymer Nanoparticles in Niemann-Pick Disease Type C | 2018 |
| 121 | MultiSpecAMYLOID | A MULTI-SPECTROSCOPIC APPROACH TO PROBE AMYLOID AGGREGATION AT BIOLOGICAL SURFACES | 2018 |
| 122 | NOJUNKDNA | A strategy to investigate cell type-specific effects of non-coding regulatory elements to be applied in neurodegeneration research | 2018 |
| 123 | NAMISTMem | Nanoscale Analytical Methods to gain insight into the Initiation of Short-Term Memory | 2018 |
| 124 | TREGinAD | Role of Aβ Specific Regulatory T cells in harnessing cerebral Aβ clearance in Alzheimer’s Disease | 2018 |
| 125 | AMNEsIA | Interactions of amyloid peptides with the neuronal membrane interface: molecular mechanisms involved in Alzheimer’s disease | 2018 |
| 126 | VirtualSync | An embodied perspective on anosognosia | 2018 |
| 127 | NeuroLSD | Neuro-metabolic, structural and functional hallmarks of Lysosomal Storage Diseases | 2018 |
| 128 | MECEDGE | Transgenic dissection of the neural circuitry of memory and dementia | 2018 |
| 129 | GFSMART | Design and Integration of Graphene Fibre Based Antennas for Smart Textiles | 2018 |
| 130 | RET PHOTOSWITCH | THE DEVELOPMENT OF NOVEL PHOTOSWITCHABLE KINASE INHIBITORS | 2018 |
| 131 | iNtoPoreAge | Assessing transcriptional and nuclear pore aging in age-equivalent and rejuvenated induced neurons from Alzheimer patients | 2019 |
| 132 | Human Glymphatics | Effects of sleep deprivation and adrenergic inhibition on glymphatic flow in humans | 2018 |
| 133 | NEVULA | Understanding selective neuronal vulnerability in Alzheimer’s disease | 2018 |
| 134 | MAPSYNE | Miniaturized automated patch-clamp system combined with high-density microelectrode arrays for multi-scale functional mapping of neuronal networks | 2018 |
| 135 | Neurocloud | CLOUD-BASED MULTIMODAL NEUROIMAGING PLATFORM | 2018 |
| 136 | NS System | A real-time and continuous brain monitoring system to record and track brain activity and extract biomarkers for neurological conditions | 2018 |
| 137 | SRIMEM | Super-Resolution Imaging and Mapping of Epigenetic Modifications | 2018 |
| 138 | NeuroProtect | Novel Drug Therapy with Potential to Cure Neuro-Degenerative Diseases | 2018 |
| 139 | DELIVER | DELIVERy of advanced therapies for diabetes training network | 2019 |
| 140 | AD Detect-Prevent | Alzheimer's Disease (AD) Detect & Prevent - Presymptomatic AD detection and prevention | 2018 |
| 141 | SAFELDER | POINT ACTIVE AGEING ASSISTIVE SERVICE – A MULTI-SENSOR SINGLE DEVICE FOR SMART MONITORING OF THE ELDERLY PEOPLE | 2018 |
| 142 | VITAE | VIrTual BrAin PErfusion: Assessing cerebrovascular function by High Performance Computing from 3D brain vessel network data for vascular-targeted drug development in neurodegenerative diseases. | 2018 |
| 143 | Mokita | The NGOs’ virtual reality content viewing platform | 2018 |
| 144 | gSKIN BodyTemp | Integration of Heat flux sensor in (wrist) wearable devices for accurately and non-invasively continuous monitoring of core body temperature (CBT) for the early detection of health-related disorders | 2018 |
| 145 | VirtualBrainCloud | Personalized Recommendations for Neurodegenerative Disease | 2018 |
| 146 | DiSCo MRI SFN | Developing Integrated Susceptibility and Conductivity MRI for Next Generation Structural and Functional Neuroimaging | 2019 |
| 147 | MeaningfulMobility | Meaningful Mobility: a novel approach to movement within and between places in later life | 2019 |
| 148 | NOAM | Navigation of a mind-space. The spatial organization of declarative knowledge | 2019 |
| 149 | RADAR-AD | Remote Assessment of Disease and Relapse – Alzheimer’s Disease | 2019 |
| 150 | IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain | 2019 |
| 151 | SensApp | Super-sensitive detection of Alzheimer’s disease biomarkers in plasma by an innovative droplet split-and-stack approach | 2019 |
| 152 | EAGER | Elucidating the effects of ageing on the nucleoporin-directed neural cell type-specific nuclear architecture and gene regulation | 2019 |
| 153 | PREMUS | Preservation and Efficacy of Music and Singing in Ageing, Aphasia, and Alzheimer’s Disease | 2019 |
| 154 | ARTSILK | Novel approaches to the generation of artificial spider silk superfibers | 2019 |
| 155 | Brain Health Toolbox | The Brain Health Toolbox: Facilitating personalized decision-making for effective dementia prevention | 2019 |
| 156 | BPET | The Next-Generation of Small, Cost-Effective and Mobile Brain Scanner for an Early Detection of Alzheimer’s Disease | 2019 |
| 157 | ProMiDis | A unified drug discovery platform for protein misfolding diseases | 2019 |
| 158 | MEMBOOST | Memory Enhancing and Learning System | 2019 |
| 159 | MicroSPARK | A Single-Molecule Technology for Resolving Chaperone Action in Neurodegenerative Diseases | 2019 |
| 160 | TRACE-AD | Tracking the Effects of Amyloid and Tau Pathology on Brain Systems and Cognition in Early Alzheimer’s Disease | 2019 |
| 161 | GPCR-MS | Molecular Details of Membrane Protein Receptor Dynamics | 2019 |
| 162 | AGEING PLASTICITY | Prefrontal plasticity underpinning resilience against cognitive ageing. | 2020 |
| 163 | UbiGolD | Deciphering ubiquitin-dependent regulation of Golgi homeostasis control in neurodegeneration | 2019 |
| 164 | COLIBRI | Click chemistry Options for Live Immuno Brain Imaging | 2019 |
| 165 | SeCRT | Uncover mechanisms of unconventional secretion of tau using functional CRISPR screens - From basic discoveries to neurodegenerative disease therapeutics | 2019 |
| 166 | PARNANT | Pathogenetic pathways in age-related neurodegenerations as novel therapeutic targets for Parkinson’s disease | 2019 |
| 167 | BILINGUALPLAS | Neurophysiological correlates of bilingual advantage and its contribution to cognitive reserve | 2020 |
| 168 | F4TGLUT | Food for thought: monitoring the effects of drugs and diet on neuronal glutamate release using nanoelectrodes | 2019 |
| 169 | STOICISM | Stochastic Communication Inside Cortical Microcolumns | 2019 |
| 170 | ViSionRF | ViSionRF: Vital Signal Monitoring using Radio-Frequency Technologies – Standard IF-RI | 2019 |
| 171 | iMIND | iPS-derived MIcroglia and Neuroinflammation in Dementia | 2020 |
| 172 | HYMNS | Hypothalamic Modulation of Neocortical States | 2020 |
| 173 | Prion Respiration | The Role of Complex I Assembly Factors during Prion Diseases: Insights into Mitochondrial Neurobiology | 2019 |
| 174 | LactaDiff | Assessing cellular compartmentation of brain lactate using diffusion MR spectroscopy in vivo | 2019 |
| 175 | PD-MIND | Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug | 2019 |
| 176 | DIVE into AD | Study of tau strains to understand the phenotypic diversity of Alzheimer’s disease: A step toward personalized therapies | 2020 |
| 177 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 178 | MeNDD | Metaphorical Narratives in Dementia Discourse | 2019 |
| 179 | NG2-cells | The role of NG2 cells in the neural network in health and disease | 2019 |
| 180 | NOCK | NOCK: Real time safety for our senior relatives. | 2019 |
| 181 | BRIGHT | 40 Hz Masked Light: A new venture to slow the progression of Alzheimer’s Disease | 2019 |
| 182 | MS-INFINITE | MASS SPECTROMETRY WITHOUT LIMITS: Pioneer MS equipment and Automated Sample Preparation unit to boost New Therapies Development | 2019 |
| 183 | TUBE | Transport derived Ultrafines and the Brain Effects | 2019 |
| 184 | ENTRAIN | ENdoThelial macRophage Alliance In Neuroinflammation | 2019 |
| 185 | STRELECOID | Stretchable mesh-electrodes interfacing human iPSC brain organoids | 2019 |
| 186 | COMMER-CELL | Commercialisation of neuronal cell co-cultures | 2019 |
| 187 | Nocturne | The eye as a window to the brain, extending lifelong brain health | 2019 |
| 188 | BrainPatch | BrainPatch – Breakthrough non-invasive brain stimulation using AI | 2019 |
| 189 | dreaMS | Digital biomarkers and treatment personalisation in multiple sclerosis | 2019 |
| 190 | VERDAD | A blood based biomarker identifying early Alzheimer Disease's pathology | 2019 |
| 191 | AmInnovation | Disruptive Innovation to Treat Alzheimer’s and Parkinson’s diseases: new target, new patented drug, new therapeutic strategy. | 2019 |
| 192 | EpiSeq | Single molecule sequencing and biophysical properties of oxidized genomic DNA using magnetic tweezers. | 2019 |
| 193 | variaTECT | A novel genetic assay for risk assessment of cognitive decline in Alzheimer’s Disease | 2019 |
| 194 | DISTINCT | Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT) | 2019 |
| 195 | ConnectToBrain | Connecting to the Networks of the Human Brain | 2019 |
| 196 | In-Cytes | IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS | 2019 |
| 197 | LIVELMIA | Innovative assay for microRNAs analysis | 2019 |
| 198 | NEUROPA | Non-invasive dynamic neural control by laser-based technology | 2020 |
| 199 | NEUREKA | A smart, hybrid neural-computo device for drug discovery | 2019 |
| 200 | ADAMtx | ADAMtx: Development of Alzheimer’s immunotherapy by harnessing the natural reparative properties of microglia | 2019 |
| 201 | NOVACHIP | Novel vascular-like BBB-on-a-chip | 2020 |
| 202 | NoBiasFluors | Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging | 2020 |
| 203 | SynLink | Molecular Structure and Engineering of Synaptic Organizer Proteins in Health and Disease | 2020 |
| 204 | CELLPHASE_AD | Genetics to understand cellular components of Alzheimer Disease pathogenesis | 2019 |
| 205 | TeNDER | affecTive basEd iNtegrateD carE for betteR Quality of Life | 2019 |
| 206 | SA-VOIR | Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other neurodegenerative diseases via a breakthrough mechanism-of-action | 2019 |
| 207 | NORATEST | NORATEST: An e-Health solution for a better Alzheimer's diagnosis and management | 2019 |
| 208 | NeuroPa | Targeting the brain sigma-1 receptor: A paradigm shift for the treatment of neuro-degenerative disorders | 2019 |
| 209 | RECOGNISED | Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia | 2020 |
| 210 | MindTrack | Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders | 2019 |
| 211 | InterTAU | Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs | 2020 |
| 212 | PRIME | Prevention and Remediation of Insulin Multimorbidity in Europe | 2020 |
| 213 | AGEMEC | Age-dependent mechanisms of sporadic Alzheimer’s Disease in patient-derived neurons | 2020 |
| 214 | DIANA | Organ-on-a-chip Drug screenIng device to tArget braiN diseAse | 2020 |
| 215 | PreSynPlast | Molecular mechanisms of presynaptic plasticity | 2020 |
| 216 | ROMB | Retina Organoid Mechanobiology | 2020 |
| 217 | CTS-TEs-ADprogress | Cell type-specific molecular analysis of epigenetic changes and transposable element derepression in Alzheimer's disease progression | 2020 |
| 218 | HESSP | Hippocampus Extracellular Space Simulator Project (HESSP) | 2020 |
| 219 | UCUPA | Unraveling the Molecular Changes that Drive the Repression of the Unfolded Protein Response with Ageing | 2020 |
| 220 | TS4NC | TS4NC: Therapeutic S4N Chelation targeting Alzheimer's Disease. | 2020 |
| 221 | AlzheimersInAction | AlzheimersInAction: A multi-disciplinary approach to determine the cellular and molecular mechanisms underlying the inflammatory response to amyloid-β in Alzheimer’s disease. | 2021 |
| 222 | MAP-AD | A multimodal approach to accelerate drug discovery and development in Alzheimer’s disease | 2021 |
| 223 | SM-SPAD | Single-molecule imaging with SPAD array detection | 2021 |
| 224 | NormNets | Normalization of Multimodal Brain Networks for Integral and Predictive Mapping of Neurological Disorders | 2020 |